2m 2m 2m 2m 2m 2m 2m
Prestige Consmer (PBH)
NYSE
$45.28+$0.50 (+1.13%)
Price as of Oct 02, 2026 4:18 PM EDT- $2.1BMarket Cap
- -28.76%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Prestige Consmer (PBH)
$45.28+$0.50 (+1.13%)
PBH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $44.77 | ||
Change | -$1.10 (-2.40%) | ||
Open | $45.76 | ||
High | $46.13 | ||
Low | $44.64 | ||
Previous Close | $45.87 | ||
Volume | 731,385 | ||
30-Day Average Volume | 615,833 | ||
1-Week Change | -1.93% | ||
1-Month Change | -14.95% | ||
1-Year Change | -28.76% | ||
3-Year Change | -21.72% | ||
5-Year Change | -19.20% | ||
Fundamentals | |||
Shares Outstanding | 47.4M | ||
Total Assets | $4.6B | ||
Market Cap | $2.1B | ||
Enterprise Value | $4.0B | ||
Period: QTR TTM FY | |||
Revenue | $260.3M | ||
Net Income | $29.2M | ||
Free Cash Flow | $67.1M | ||
EBIT | $52.5M | ||
EBITDA | $61.2M | ||
Net Working Capital | $343.0M | ||
EPS | $0.61 | ||
Enterprise Value/EBITDA | 66 | ||
Enterprise Value/Revenue | 16 | ||
P/B | 1 | ||
P/E | 73 | ||
PEG | -2 | ||
Price/Free Cash Flow | 32 | ||
Price/Operating Cash Flow | 30 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 12/27/2013 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue